Cu, Zn- And Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis

Journal of Neural Transmission

Volumn 111, Issue 9, 2004, Pages 1191-1201

  Michel, T M ^a   Thome, J ^b   Martin, D ^a   Nara, K ^c   Zwerina, S ^a   Tatschner, T ^a   Weijers, H G ^a   Koutsilieri, E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Antipsychotic drugs; Brain; Free radicals; Post mortem; Psychosis; Schizophrenia

Indexed keywords

ANTIOXIDANT; BRAIN ENZYME; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BLOOD CELL; BRAIN TISSUE; CAUDATE NUCLEUS; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; OCCIPITAL CORTEX; OXIDATIVE STRESS; PARIETAL LOBE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; PUTAMEN; SCHIZOPHRENIA; SUBSTANTIA INNOMINATA; TEMPORAL CORTEX; THALAMUS; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BRAIN; FEMALE; FRONTAL LOBE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OXIDATIVE STRESS; SCHIZOPHRENIA; SUBSTANTIA INNOMINATA; SUPEROXIDE DISMUTASE; UP-REGULATION;

EID: 4544387807     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0160-9     Document Type: Article

References (49)

1. Akyol O, Herken H, Uz E, Fadillioglu E, Unal S, Sogut S, Ozyurt H, Savas HA (2002) The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 26: 995-1005
2. Altuntas I, Aksoy H, Coskun I, Caykoylu A, Akcay F (2000) Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin Chem Lab Med 38: 1277-1281
3. Averback P (1981) Lesions of the nucleus ansae peduncularis in neuropsychiatric disease. Arch Neurol 38: 230-235
4. Bloom FE (1993) Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 50: 224-227
5. Bogerts B (2002) Bedeutung des Frontalhinrs für die Pathophysiologie schizophrener Erkrankungen. In: Förstl (ed) Frontalhirn. Springer, Berlin Heidelberg New York Tokyo, pp 182-205
6. Brown K, Reid A, White T, Henderson T, Hukin S, Johnstone C, Glen A (1998) Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry 43: 863-867
7. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S (1990) Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry 156: 216-227
8. Carlsson A, Waters N, Carlsson ML (1999) Neurotransmitter interactions in schizophrenia-therapeutic implications. Biol Psychiatry 46: 1388-1395
9. Cavelier L, Jazin EE, Eriksson I, Prince J, Bave U, Oreland L, Gyllensten U (1995) Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. Genomics 29: 217-224
10. Chignell CF, Motten AG, Buettner GR (1985) Photoinduced free radicals from chlorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization. Environ Health Perspect 64: 103-110
11. Durany N, Michel T, Zochling R, Boissl KW, Cruz-Sanchez FF, Riederer P, Thome J (2001) Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr Res 52: 79-86
12. Gong L, Wyatt RJ, Baker I, Masserano JM (1999) Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death. Neurosci Lett 263: 153-156
13. Gsell W, Lange K, Pfeuffer L, Heckers S, Heinsen H, Senitz D, Jellinger K, Ransmayr G, Wichart R, Vock R, Beckmann H, Riederer P (1993) How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39: 31-70
14. Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O (2001) Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 6: 66-73
15. Ikeda O, Murakami M, Ino H, Yamazaki M, Koda M, Nakayama C, Moriya H (2002) Effects of brain-derived neurotrophic factor (BDNF) on compression-induced spinal cord injury: BDNF attenuates down-regulation of superoxide dismutase expression and promotes upregulation of myelin basic protein expression. J Neuropathol Exp Neurol 61: 142-153
16. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303-326
17. Kendler KS (2003) The genetics of schizophrenia: chromosomal deletions, attentional disturbances, and spectrum boundaries. Am J Psychiatry 160: 1549-1553
18. Khan MM, Parikh VV, Mahadik SP (2003) Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. J Neurochem 86: 1089-1100
19. Khan NS, Das I (1997) Oxidative stress and superoxide dismutase in schizophrenia. Biochem Soc Trans 25: 418S
20. Kornhuber J, Weller M (1994) [Current status of biochemical hypotheses in the pathogenesis of schizophrenia]. Nervenarzt 65: 741-754
21. Koutsilieri E, Scheller C, Grunblatt E, Nara K, Li J, Riederer P (2002) Free radicals in Parkinson's disease. J Neurol 249 [Suppl 2]: II1-II5
22. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20: 171-175
23. Li XM, Juorio AV, Qi J, Boulton AA (1998) L-deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cells. J Neurosci Res 53: 235-238
24. Loven DP, James JF, Biggs L, Little KY (1996) Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients. Biol Psychiatry 40: 230-232
25. Lowry OH, Rosebrough NJ, Farr AL, Raudell RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275
26. Mahadik SP, Mukherjee S (1996a) Cultured skin fibroblasts as a cell model for investigating schizophrenia. J Psychiatr Res 30: 421-439
27. Mahadik SP, Mukherjee S (1996b) Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19: 1-17
28. Mahadik SP, Mukherjee S, Laev H, Reddy R, Schnur DB (1991) Abnormal growth of skin fibroblasts from schizophrenic patients. Psychiatry Res 37: 309-320
29. Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS (1998) Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry 43: 674-679
30. McCreadie RG, MacDonald E, Wiles D, Campbell G, Paterson JR (1995) The Nithsdale Schizophrenia Surveys. XIV. Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects. Br J Psychiatry 167: 610-617
31. Mukherjee S, Mahadik SP, Schnur DB, Laev H, Reddy R (1994) Abnormal growth of cultured skin fibroblasts associated with poor premorbid history in schizophrenic patients. Schizophr Res 13: 233-237
32. Pall HS, Williams AC, Blake DR, Lunec J (1987) Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet 2: 596-599
33. Parikh V, Khan MM, Mahadik SP (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37: 43-51
34. Pearce BD (2001) Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Mol Psychiatry 6: 634-646
35. Phillips M, Sabas M, Greenberg J (1993) Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol 46: 861-864
36. Pinikahana J, Happell B, Keks NA (2003) Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing. Issues Ment Health Nurs 24: 27-43
37. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121: 109-122
38. Saito T, Ito K, Kurasaki M, Fujimoto S, Kaji H, Saito K (1982) Determination of true specific activity of superoxide dismutase in human erythrocytes. Clin Sci (Lond) 63: 251-255
39. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M (2001) Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology (Berl) 158: 140-145
40. Stevens JR (1982) Neuropathology of schizophrenia. Arch Gen Psychiatry 39: 1131-1139
41. Suboticanec K, Folnegovic-Smalc V, Korbar M, Mestrovic B, Buzina R (1990) Vitamin C status in chronic schizophrenia. Biol Psychiatry 28: 959-966
42. Thome J, Foley P, Riederer P (1998) Neurotrophic factors and the maldevelopmental hypothesis of schizophrenic psychoses. Review article. J Neural Transm 105: 85-100
43. Wang FS, Wang CJ, Sheen-Chen SM, Kuo YR, Chen RF, Yang KD (2002) Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. J Biol Chem 277: 10931-10937
44. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669
45. Yao JK, Reddy R, van Kammen DP (1998) Reduced level of plasma antioxidant uric acid in schizophrenia. Psychiatry Res 80: 29-39
46. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15: 287-310
47. Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY (2003a) Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms. Psychiatry Res 117: 85-88
48. Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (2003b) The effect of risperidone treatment on superoxide dismutase in schizophrenia. J Clin Psychopharmacol 23: 128-131
49. Zhou D, Zhang X, Su J, Nan Z, Cui Y, Liu J, Guan Z, Zhang P, Shen Y (1999) The effects of classic antipsychotic haloperidol plus the extract of ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia. Chin Med J (Engl) 112: 1093-1096